GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) » Definitions » Cost of Goods Sold

Wai Yuen Tong Medicine Holdings (HKSE:00897) Cost of Goods Sold : HK$691 Mil (TTM As of Sep. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Wai Yuen Tong Medicine Holdings Cost of Goods Sold?

Wai Yuen Tong Medicine Holdings's cost of goods sold for the six months ended in Sep. 2023 was HK$355 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Sep. 2023 was HK$691 Mil.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Wai Yuen Tong Medicine Holdings's Gross Margin % for the six months ended in Sep. 2023 was 47.73%.

Cost of Goods Sold is also directly linked to Inventory Turnover. Wai Yuen Tong Medicine Holdings's Inventory Turnover for the six months ended in Sep. 2023 was 0.22.


Wai Yuen Tong Medicine Holdings Cost of Goods Sold Historical Data

The historical data trend for Wai Yuen Tong Medicine Holdings's Cost of Goods Sold can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wai Yuen Tong Medicine Holdings Cost of Goods Sold Chart

Wai Yuen Tong Medicine Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cost of Goods Sold
Get a 7-Day Free Trial Premium Member Only Premium Member Only 449.92 339.17 663.28 821.02 674.65

Wai Yuen Tong Medicine Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Cost of Goods Sold Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 380.87 440.15 337.94 336.71 354.78

Wai Yuen Tong Medicine Holdings Cost of Goods Sold Calculation

Cost of Goods Sold is the aggregate cost of goods produced and sold, and services rendered during the reporting period. It excludes Total Operating Expense, such as Depreciation, Depletion and Amortization and Selling, General, & Admin. Expense.

Cost of Goods Sold for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$691 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wai Yuen Tong Medicine Holdings  (HKSE:00897) Cost of Goods Sold Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Wai Yuen Tong Medicine Holdings's Gross Margin % for the six months ended in Sep. 2023 is calculated as:

Gross Margin %=(Revenue - Cost of Goods Sold) / Revenue
=(678.804 - 354.777) / 678.804
=47.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:

Wai Yuen Tong Medicine Holdings's Inventory Turnover for the six months ended in Sep. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.


Wai Yuen Tong Medicine Holdings Cost of Goods Sold Related Terms

Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's Cost of Goods Sold provided by GuruFocus.com. Please click on the following links to see related term pages.


Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description

Traded in Other Exchanges
N/A
Address
39 Wang Kwong Road, Suite 3101, 31st Floor, Skyline Tower, Kowloon Bay, Kowloon, Hong Kong, HKG
Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.
Executives
Wang On Group Limited 2501 Other
Tang Ching Ho 2501 Other
Yau Yuk Yin 2202 Interest of your spouse

Wai Yuen Tong Medicine Holdings (HKSE:00897) Headlines

No Headlines